• Return to Headlines

Momenta Pharmace Has Returned 60.1% Since SmarTrend Recommendation (MNTA)

By Nick Russo

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on October 18th, 2017 at $14.55. In approximately 8 months, Momenta Pharmace has returned 60.14% as of today's recent price of $23.30.

In the past 52 weeks, shares of Momenta Pharmace have traded between a low of $9.66 and a high of $24.90 and are now at $23.30, which is 141% above that low price. The 200-day and 50-day moving averages have moved 0.71% higher and 1.66% higher over the past week, respectively.

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Momenta Pharmace shares.

Log in and add Momenta Pharmace (MNTA) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights momenta pharmace

Ticker(s): MNTA